Celcuity, Inc. (NASDAQ:CELC) Director Richard Nigon bought 7,500 shares of the stock in a transaction on Tuesday, November 28th. The stock was purchased at an average cost of $17.48 per share, with a total value of $131,100.00. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Richard Nigon also recently made the following trade(s):
- On Tuesday, November 21st, Richard Nigon bought 8,500 shares of Celcuity stock. The stock was purchased at an average cost of $17.31 per share, with a total value of $147,135.00.
Shares of Celcuity, Inc. (NASDAQ:CELC) traded down $1.16 during trading hours on Wednesday, reaching $17.59. 32,000 shares of the company’s stock traded hands, compared to its average volume of 45,633. Celcuity, Inc. has a 1 year low of $11.10 and a 1 year high of $21.98.
Separately, Craig Hallum started coverage on shares of Celcuity in a research note on Monday, October 16th. They issued a “buy” rating for the company.
Celcuity Company Profile
Celcuity, Inc is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the targeted therapy that best treats it.
Receive News & Ratings for Celcuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.